Dysphonia
43
5
5
23
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
4.7%
2 terminated out of 43 trials
92.0%
+5.5% vs benchmark
14%
6 trials in Phase 3/4
26%
6 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (43)
Usefulness and Feasibility of Ultrasound in Office Laryngology Procedures
A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring
Voice and Swallowing Outcomes Following Revision Anterior Cervical Spine Surgery
PhoRTE® Therapy Efficacy: In-Person Versus Telehealth
A Personalized Voice Restoration Device for Patients With Laryngectomy
Clinical Validation of DystoniaNet Deep Learning Platform for Diagnosis of Isolated Dystonia
Assessing the Effects of Patient Self-Rating of Voice Quality on Voice Therapy Attendance and Outcomes
Deconstructing Voice Therapy: Towards Enhanced Communication Outcomes
No Post Intubation Laryngeal Symptoms
Translaryngeal Vibration for Hyperfunctional Voice Disorders
The Mechanism Versus PPI Trial
Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice
Dysphonia, Distress, and Perceived Control: Technology Based Assessment and Intervention
The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy
Characterization of "Bamboo" and Other Vocal Cord Lesions Responsible for Dysphonia in Patients With Systemic Autoimmune Diseases (BAMBOO)
Voice and Swallowing Disorders in Adults With and Without Alzheimer's Disease
Effect of Semi-occluded Vocal Tract Therapy on the Phonation of Children With Vocal Fold Nodules
The Effect of IV NSAID's and Corticosteroids on Dysphasia and Dysphonia Following ASDF
Intensive Versus Traditional Voice Therapy